Eurlexa

English
- Sign in
- Register

Commission Regulation (EU) 2024/848 of 14 March 2024 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate with effect from 1 April 2024

Basic information

No longer in force
CELEX number: 32024R0848
Official Journal: L_202400848
Form: Regulation
Procedure number: --
Languages:
- bg
- cs
- da
- de
- el
- en
- et
- fi
- fr
- ga
- hr
- hu
- it
- lv
- lt
- mt
- nl
- pl
- pt
- ro
- sk
- sl
- es
- sv

Dates

Date of document:

March 14, 2024

Date of publication:

--

Date of effect:

March 16, 2024
- Entry into force - Date pub. +1 See Art 3
April 1, 2024
- Application - See Art 3

Date of end of validity:

December 31, 2024
- Linked to 31995R0297

Modified by

Modifies

Modifies:

Règlement (CE) n° 297/95 du Conseil, du 10 février 1995, concernant les redevances dues à l'agence européenne pour l'évaluation des médicaments

Affected by case

Legal basis

Council Regulation (EC) No 297/95 of 10 February 1995 on fees payable to the European Agency for the Evaluation of Medicinal Products

EuroVoc Vocabulary

European Medicines Agency
Internal market - Principles
Medicinal product
Inflation
Market approval
Proprietary medicinal products
Veterinary medicinal product